The structural similarity between the pilin glycan and the O-antigen of Pseudomonas aeruginosa 1244 suggested that they have a common metabolic origin. Mutants of this organism lacking functional wbpM or wbpL genes synthesized no O-antigen and produced only non-glycosylated pilin. Complementation with plasmids containing functional wbpM or wbpL genes fully restored the ability to produce both O-antigen and glycosylated pilin. Expression of a cosmid clone containing the O-antigen biosynthetic gene cluster from P. aeruginosa PA103 (LPS serotype O11) in P. aeruginosa 1244 (LPS serotype O7) resulted in the production of strain 1244 pili that contained both O7 and O11 antigens. The presence of the O11 repeating unit was confirmed by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry. Expression of the O-antigen biosynthesis cluster from Escherichia coli O157:H7 in strain 1244 resulted in the production of pilin that contained both the endogenous Pseudomonas as well as the Escherichia O157 O-antigens. A role for pilO in the glycosylation of pilin in P. aeruginosa is evident as the cloned pilAO operon produced glycosylated strain 1244 pilin in eight heterologous P. aeruginosa strains. Removal of the pilO gene resulted in the production of unmodified strain 1244 pilin. These results show that the pilin glycan of P. aeruginosa 1244 is a product of the Oantigen biosynthetic pathway. In addition, the structural diversity of the O-antigens used by the 1244 pilin glycosylation apparatus indicates that the glycan substrate specificity of this reaction is extremely low.
Introduction
The pili of Pseudomonas aeruginosa are protein fibres that radiate from one or both cell poles (Paranchych and Frost, 1988; Strom and Lory, 1993) . These structures are important in cell adhesion (Hahn, 1997) and are responsible for twitching motility (Bradley, 1980; Wall and Kaiser, 1999) , a form of cell movement involved in the establishment and spreading of this opportunistic pathogen (Kang et al ., 1997; Comolli et al ., 1999) . The pili of P. aeruginosa are made up of a single type of pilin subunit, which has the physical and chemical characteristics associated with those of the type IV pili (Paranchych and Frost, 1988; Strom and Lory, 1993) . One of these characteristics is the N-methylation of the amino-terminal residue, phenylalanine. In addition to this modification, the pilin of P. aeruginosa 1244 is glycosylated (Castric, 1995) . This process requires the presence of pilO , a gene that is a component of an operon containing pilA , the pilin structural gene. Although once considered rare, glycosylation of prokaryotic protein is now known to occur in a variety of organisms (Messner and Schaffer, 2002) . This modification is most commonly found in proteins associated with the cell surface, the best studied example being the archaeal and eubacterial S-layer glycoproteins (Messner and Schaffer, 2002) . More recently, a number of examples of glycosylated surface proteins from pathogens have been demonstrated. Among Gram-positive organisms, proteins of Streptococcus sanguis and Mycobacterium tuberculosis have been shown to be glycosylated (Erickson and Herzberg, 1993; Dobos et al ., 1995) . Examples of glycosylation of surface proteins among the Gram-negative pathogens include adhesins of Escherichia coli (Lindenthal and Elsinghorst, 1999; Benz and Schmidt, 2001) , an outer membrane protein of Chlamydia trachomatis (Kuo et al ., 1996) , the flagella of Campylobacter species Thibault et al ., 2001) and P. aeruginosa (Brimer and Montie, 1998; Arora et al ., 2001) , and the pili of Neisseria meningitidis and N. gonorrhoeae (Parge et al ., 1995; Stimson et al ., 1995; Stimson et al ., 1996) . © 2002 Blackwell Publishing Ltd, Molecular Microbiology , 46 , 519-530 Examination of P. aeruginosa 1244 pili has shown that each subunit contains a single covalently bound glycan (Castric et al ., 2001 ) that is attached to serine 148 (Comer et al ., 2002) , the carboxy-terminal pilin residue. Structural analysis has revealed the glycan to be a trisaccharide, a -5N b OHC 4 7NFmPse-(2 AE 4)-b -Xyl-(1 AE 3)-b -FucNAc, which is attached to the serine b carbon through the C-1 of FucNAc (Castric et al ., 2001 ). These sugars, in the same order and linkage, are found in the serotype O7 (International Antigenic Typing System (IATS; Liu et al ., 1983) O-antigen, the serogroup to which strain 1244 belongs. These findings suggested that the pilin glycan and the O-antigen of this organism have a common metabolic origin.
The genes required for biosynthesis of the O-antigens of P. aeruginosa serotypes O5, O6 and O11 have been characterized (Burrows et al ., 1996; Belanger et al ., 1999; Dean et al ., 1999) , and two genes, wbpM and wbpL , have been shown to be essential for the initial steps of Oantigen biosynthesis. wbpM encodes a bifunctional UDPGlcNAc C6 dehydratase/C4 reductase that is essential for the formation of the nucleotide precursor UDP-QuiNAc (Burrows et al ., 1996; Cruezenet and Lam, 2001) . This sugar nucleotide is converted into UDP-FucNAc by a subsequent epimerization step and is the precursor for the first sugar residue of the serotype O7 O-antigen unit. WbpL, a bifunctional glycosyltransferase, is required for the initiation of both A-band lipopolysaccharide (LPS; common antigen) and B-band LPS (O antigen) synthesis (Burrows et al ., 1996; Rocchetta et al ., 1998) . This transferase initiates the assembly of individual O-antigen units by the transfer of FucNAc from UDP-FucNAc to undecaprenol phosphate. Consequently, mutations in wbpM in P. aeruginosa strains PAO1 (serotype O5) and PAK (serotype O6) result in the complete loss of O-antigen production, whereas null mutations in wbpL completely abolish the production of both A-band and O-antigen LPS. Therefore, wbpL and wbpM are ideal targets for constructing null mutants to investigate the role of O-antigen biosynthesis in the glycosylation of strain 1244 pilin.
We provide evidence in this paper that the pilin glycan is a product of the O-antigen biosynthetic pathway. This is performed using defined wbpM and wbpL mutants derived in the P. aeruginosa 1244 strain background. These results are confirmed by the finding that cloned biosynthesis gene clusters coding for heterologous Oantigen result in the production of pili containing heterologous O-antigen. Of particular significance is the evidence that the pilin glycosylation apparatus is nonselective with regard to O-antigen structure, showing no apparent specificity as to saccharide size, charge or structure. These results contribute to the understanding of pilus structure and function, and have important implications in pilus and LPS targeted vaccine design.
Results

Generation and analysis of 1244 wbpM and wbpL mutants
As wbpL and wbpM are involved in the initial steps of Oantigen biosynthesis, mutants of these genes in P. aeruginosa 1244 were generated to investigate whether the O7 O-antigen and the pilin glycan were products of this metabolic pathway. The nucleotide sequence for the wbp cluster in strain 1244 was unknown. However, based on the findings from previous studies (Burrows et al ., 1996; Belanger et al ., 1999) , it was known that a highly conserved wbpM gene is located at the 3 ¢ end of the wbp cluster, and that wbpL is localized upstream of wbpM in a non-conserved serotype-specific region. The wbpL gene in strain 1244 ( wbpL 1244 ) could not be identified in Southern blot analysis even using low-stringency conditions. Therefore, taking advantage of the highly conserved nature of wbpM at the nucleotide level, a 1244 wbpM null mutant was first generated following an established method (Schweizer and Hoang, 1995) using an allelic replacement construct containing the wbpM gene from P. aeruginosa strain PAO1 (serotype O5) interrupted with a gentamicin resistance cassette (Burrows et al ., 1996) . Southern blot analysis was performed on Xho I-digested chromosomal DNA from P. aeruginosa strain PAO1, 1244 wild type and the 1244 wbpM mutant using wbpM PAO1 as a gene probe (data not shown). The wbpM gene contains one XhoI site; therefore, the wbpM PAO1 probe hybridized to two DNA fragments from each strain. A wbpM probe-reactive fragment of 1.6 kb was observed in all three strains. Based on the available nucleotide sequence of the PAO1 wbp cluster (Burrows et al., 1996; Stover et al., 2000) , it was deduced that the 1.6 kb fragment corresponds to the 3¢ end of the wbpM gene (Fig. 1) . wbpM probe-reactive DNA fragments of sizes 4.3 kb, 2.2 kb and 3.1 kb were also observed from PAO1, 1244 wild type and the wbpM mutant respectively (Fig. 1) . These DNA fragments correspond to the 5¢ end of wbpM and upstream DNA containing the less conserved serotype-specific region. Cloning and nucleotide sequening analysis of the 3 kb XhoI fragment from the 1244 wbpM mutant revealed a complete open reading frame (ORF) at the 5¢ end composed of 1041 nucleotides, which encodes a 346-amino-acid protein with 58% identity and 74% similarity to WbpL from P. aeruginosa strain PAO1. In addition, the protein encoded by this ORF contained five conserved motifs characteristic of the WbpL-type family of glycosyltransferases (Rocchetta et al., 1998) , which belong to a larger family of UDP-GlcNAc/ MurNAc:polyisoprenol-P GlcNAc/MurNAc-1-P transferases (Lehrman, 1994) . This ORF was designated wbpL 1244 , and a wbpL 1244 null mutant was successfully constructed using the gene replacement method described earlier (Schweizer and Hoang, 1995) . Analysis of the LPS from 1244 wbpM and wbpL mutants showed that they are both deficient in B-band production, whereas the wbpL mutant is also deficient in A-band production (Fig. 2) . Complementation experiments transforming wbpM (pFV163-26; wbpM PAO1 ) and wbpL (pFVAB3-26; wbpL 1244 ) into their respective mutants restored the phenotype to that of the parent (Fig. 2) . The GenBank accession numbers for these genes are AY095101 for wbpL 1244 and AF508154 for wbpM 1244 .
Pilin glycosylation state of 1244 wbpM and wbpL mutants
If the 1244 pilin glycan originates in the O-antigen pathway, it would be expected that mutants defective in biosynthesis of this polysaccharide would produce altered pilin glycosylation. To test this, the wbpM and wbpL 1244 mutants were analysed by Western immunoblotting to determine whether they produced pilin of a size and charge consistent with glycosylation. The pilin from each of these mutants was of an apparent molecular weight consistent with non-glycosylated pilin (Fig. 3A) . Complementation of these mutants resulted in the production of pilin with the same molecular weight as authentic glycosylated 1244 pilin. To confirm these results, pilin produced by the mutants was separated by isoelectric focusing, blotted and probed with monoclonal antibodies, specific in one case for 1244 pilin protein and in the other for pilin glycan. It has been demonstrated previously that nonglycosylated 1244 pilin focuses at approximately pH 6.25, whereas glycosylated pilin has a pI of 4.75 (Castric, 1995) . The pIs of the pilin from the wbpM and wbpL mutants were identical and matched that of nonglycosylated pilin, whereas the complemented mutants produced pilin with acidic isoelectric points indistinguishable from that of glycosylated pilin (Fig. 3B ). In addition, the pilins from the complemented strains reacted with the glycan-specific monoclonal antibody 11.14, whereas the mutant pilins were non-reactive (Fig. 3C ). These data showed that 1244 mutants defective in either the N-acetylfucosamine pathway (wbpM) or the initial transferase responsible for attachment of this sugar to the undecaprenol carrier lipid (wbpL) were unable to produce glycosylated pilin. Altogether, these results support the proposal (Castric et al., 2001 ) that the O-antigen biosynthetic pathway is the metabolic source of the pilin glycan.
Heterologous pilin glycosylation by P. aeruginosa 1244
If the O-antigen biosynthetic pathway is the source of the Silver-stained SDS-PAGE gel (A) and Western immunoblots using the O7 B-band specific mAb MF29-2 (B) and Aband specific mAb N1F10 (C). The 1244 wbpM and wbpL mutants are both deficient in B-band LPS, whereas the wbpL mutant is also deficient in A-band LPS. LPS of the wbpM and wbpL mutants is restored to that of the parent phenotype when complemented by pFV163-26 (wbpM PAO1 ) and pFVAB3-26 (wbpL 1244 ) respectively.
glycan, and the glycan is identical to the O-antigen repeating unit, a question concerning pilin glycan substrate specificity arises. The high degree of variability in P. aeruginosa O-antigen structure (Knirel, 1990) suggests that there is either more than one glycosylating system available to this organism, depending on O-antigen, or one type of glycosylation machinery that is non-specific with regard to glycan structure.
To examine the glycan substrate specificity question, heterologous cloned O-antigen biosynthetic clusters were expressed in strain 1244, and the pilin produced was tested for glycosylation. To do this, the cloned O-antigen biosynthesis cluster from a serotype O11 strain of P. aeruginosa, contained in cosmid pLPS2, was mobilized into strain 1244 by triparental mating. Western immunoblotting analysis using O-specific antisera (Fig. 4A and B) showed that this strain produced O11 as well as host (O7) O-antigen. This indicated that the O-antigen transport and assembly apparatus of strain 1244 was compatible with the O-antigen repeating units of P. aeruginosa O11. However, these results were not conclusive to indicate that the pilin in the transformed strains is glycosylated with O11, O7 or both O-antigen sugars as their glycan constituents.
Pilin glycosylated with the cloned O-antigen repeating unit would be difficult to detect by Western immunoblotting using pilin-specific antibodies as this protein would have approximately the same molecular weight as native glycosylated pilin. In addition, the presence of LPS in the pilus preparations would preclude the use of LPS-specific sera in these blots. Therefore, pilin produced by P. aeruginosa 1244 (pLPS2) was subjected to isoelectric focusing to separate LPS from pilin, blotted to nitrocellulose and probed with pilin-specific and O-antigen-specific antibodies. Probing with a pilin-specific monoclonal antibody ( Fig. 4C ) showed that pilin from P. aeruginosa 1244 (pLPS2) was produced in both an acidic and a more neutral form. The pI of the acidic form matched that of wild-type glycosylated 1244 pilin, whereas the more neutral form co-migrated with non-glycosylated pilin. However, a Western immunoblot of this material, using a pilin protein-specific monoclonal antibody, indicated that no non-glycosylated pilin was present (results not shown). The O11 repeating unit, unlike the O7 repeating unit, is uncharged (Knirel, 1990) and, if attached to pilin, would produce a migration pattern identical to that of the nonglycosylated form. The presence of two pilin forms, differing by only glycan, was supported by probing identical blots with antisera specific for either the O11 antigen or the O7 antigen. Only the more neutral pilin form reacted with the O11-specific monoclonal antibody (Fig. 4D) , whereas the acidic form reacted only with the O7 antibody (Fig. 4E) . These results indicate that two populations of glycosylated pilins were produced. One contained bound O7 repeating unit, while the other had the O11 antigen subunit attached.
To substantiate the above findings further, matrixassisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometric (MS) analysis was performed on purified pilin from the transconjugant strain P. aeruginosa 1244 (pLPS2). Non-glycosylated mature 1244 pilin Immunoblot analysis of pilin produced by P. aeruginosa 1244 wbpM and wbpL mutants. Western blot of cell extracts using anti-1244 pilin mAb 6.45 as probe (A). Immunoblot of pilin separated by electrofocusing using anti-1244 pilin mAb 6.45 (B) or anti1244 pilin glycan mAb 11.14 (C) as probe. NG pilin is non-glycosylated 1244 pilin, and G is glycosylated pilin from the same strain. The 1244 wbpM and wbpL mutants both produce only non-glycosylated pilin. Complementation of these mutants with pFV163-26 (wbpM PAO1 ) and pFVAB3-26 (wbpL 1244 ), respectively, restored the ability to form glycosylated pilin.
is predicted to have a mass of 15 648 Da (Castric, 1995) . Addition of the glycan mass, 666, would give 16 313, a value consistent with that determined previously (Castric et al., 2001) . Strain 1244 (pLPS2) pilin containing the O11 repeating unit, as defined by Knirel (1990) , would be predicted to have a mass of 16 183. MALDI-TOF MS analysis of pure pilin produced by P. aeruginosa 1244 (pLPS2) showed two major peaks (results not shown). The base peak occurred at a mass of m/z 16 187 (±10), a value that corresponded closely to pilin glycosylated with the O11 repeating unit. In contrast, analysis of glycosylated pilin produced from P. aeruginosa 1244 showed no peak at this mass. In addition, the putative heterologously glycosylated pilin produced a 30% base peak with a mass of m/z 16 316 (±25), a size nearly identical to that predicted for glycosylated 1244 pilin.
To determine whether the O-antigen pathway from a source other than Pseudomonas could serve as the glycan source for pilin glycosylation, the O-antigen biosynthetic cluster from Escherichia coli O157:H7 was expressed in P. aeruginosa 1244. Results from the Western immunoblotting analysis showed that the biosynthesis cluster from E. coli O157:H7, expressed from pDIG5, was able to support production of the E. coli O-antigen in P. aeruginosa 1244 (Fig. 5A and B) . In addition, strain 1244 was able concomitantly to produce its own O-antigen. These results suggest that there is no incompatibility between the LPS assembly pathway of strain 1244 and the E. coli O157 O-antigen. The transconjugant strain P. aeruginosa 1244 (pDIG5) produced two electrophoretically distinct forms of 1244 pilin (Fig. 5C ), one of which has a pI of ª 6.25 and corresponded to non-glycosylated 1244 pilin. No non-glycosylated pilin was detected in this preparation using Western blot with a pilin protein-specific monoclonal antibody (results not shown). The other pilin form has a pI of ª 4.75 and co-migrated with the glycosy Fig. 4 . Immunoblot analysis of LPS and pilin produced by P. aeruginosa 1244 (pLPS2). Western blot of LPS from P. aeruginosa 1244, E. coli HB101, P. aeruginosa 1244 (pLPS2) and E. coli HB101 (pLPS2) probed with anti-O11 mAb O11 (A) or anti-O7 mAb 11.14 (B). Immunoblot of pilin from P. aeruginosa 1244 (pLPS2) separated by electrofocusing and probed with anti1244 pilin mAb 6.45 (C), anti-O11 mAb O11 (D) or anti-O7 mAb 11.14 (E). P. aeruginosa 1244 (pLPS2) produces LPS containing both O7 and O11 antigen and glycosylates its pilin with both these antigens.
Fig. 5.
Immunoblot analysis of LPS and pilin produced by P. aeruginosa 1244 (pDIG5). Western blot of LPS from P. aeruginosa 1244, E. coli HB101, P. aeruginosa 1244 (pDIG5) and E. coli HB101 (pDIG5) probed with an O157-specific polyclonal serum (A) or anti-O7 mAb 11.14 (B). Immunoblot of pilin from P. aeruginosa 1244 (pDIG5) separated by electrofocusing and probed with anti-1244 pilin mAb 6.45 (C), an O157-specific polyclonal serum (D) or anti-O7 mAb 11.14 (E). P. aeruginosa 1244 (pDIG5) produces LPS containing both E. coli O157 and P. aeruginosa O7 antigen and glycosylates its pilin with both these antigens. lated form of 1244 pilin. Only the more neutral form of these pilins reacted with a polyclonal antiserum specific for the E. coli O157 O-antigen (Fig. 5D) . The acidic pilin form reacted only with a monoclonal antibody specific for the P. aeruginosa O7 O-antigen (Fig. 5E ). These results suggest that a fraction of the pilin subunits produced were glycosylated with the O157 repeating unit, whereas the remainder contains the O7 antigen.
Altogether, the results presented here provide concrete evidence that the O-antigen biosynthesis pathway serves as the metabolic source of the 1244 pilin glycan. In addition, they indicate that the glycosylation apparatus of strain 1244 has broad specificity. It is apparent that strain 1244 could use glycans that are significantly different in size, structure and charge from the homologous substrate.
Glycosylation of 1244 pilin by heterologous P. aeruginosa strains
Previous work has shown that PilO is an absolute requirement for pilin glycosylation in P. aeruginosa 1244 (Castric, 1995) . As cloned heterologous O-antigen biosynthesis clusters can serve as a glycan source in strain 1244, it might be possible for PilO from this strain to be able to glycosylate 1244 pilin in heterologous strains if no other pilin-specific glycosylation elements were required. To investigate this, a cloned 1244 structural gene (pilA) was expressed in eight P. aeruginosa strains heterologous for O-antigen, in either the presence or the absence of pilO.
As none of the strains tested produced pilin that reacted with the 1244 pilin-specific monoclonal antibody used in the assay, this strategy allowed for the unambiguous determination of heterologous pilin. Figure 6 shows the results of an experiment using one of these strains, P. aeruginosa PA103 (serotype O11), which lacks a pilO gene, as determined by Southern blot using 1244 pilO as a probe (S. Bish and P. Castric, unpublished observations) . This organism, containing only the vector control (pMMB66EH), produced no 1244 pilin, as determined by Western immunoblotting (Fig. 6A) . The presence of strain 1244 pilA in the absence of pilO (pPAC24) resulted in the production of strain 1244 pilin with an apparent molecular weight equivalent to that of the non-glycosylated form. The inclusion of pilO (pPAC46) significantly increased the 1244 pilin molecular weight, suggesting that this protein had been post-translationally modified. The size difference between this protein and standard glycosylated pilin would be consistent with the presence of the O11 Oantigen repeating unit which, as described above, is smaller than the O7 structure (Fig. 6A) .
To determine whether 1244 pilin produced by PA103 (pPAC46) contained bound O11 antigen, this protein was separated from contaminating LPS by isoelectric focusing, blotted and probed with antibodies specific for either 1244 pilin protein or the O11 antigen. The 1244 pilin produced by pPAC24 focuses at approximately pH 6.25 (Fig. 6B) , which is equivalent to the pI of non-glycosylated 1244 pilin described in an earlier study (Castric, 1995) . As the O11 polysaccharide repeating unit is uncharged, pilin containing this structure would be expected to have the same pI as non-glycosylated 1244 pilin, as described above. Only 1244 pilin produced in the presence of the pilO gene product reacted with the anti-O11 monoclonal (Fig. 6C) , indicating that the protein contained bound O-antigen. These data suggest that PilO is capable of attaching the O11 repeating unit to 1244 pilin, indicating a low glycan specificity in the glycosylation reaction. These results were reproducible when the 1244 pilin expression was tested in seven other P. aeruginosa strains that produced structurally distinct O-antigens of differing serotypes: 1410 (O2), PAO1 (O5), PAKN1 (O6), 5870 (O13), 4239 (O16), 8433 (O19) and 7706 (non-typeable clinical isolate). In each case, 1244 pilin was produced only in the Fig. 6 . Immunoblot analysis of pilin produced by P. aeruginosa 1244 (pPAC24) and P. aeruginosa 1244 (pPAC46). Western blot of cell extracts using anti-1244 pilin mAb 6.45 as probe (A). Immunoblot of pilin separated by electrofocusing using anti-1244 pilin mAb 6.45 (B) or anti-O11 mAb O11 (C) as probe. NG pilin is non-glycosylated 1244 pilin, and G is glycosylated pilin from the same strain. Strain 1244 pilin produced in strain PA103 in the presence of the pilO gene is glycosylated with O11 antigen. presence of either pPAC24 or pPAC46. As with strain PA103, glycosylated pilin was detected only when the pilO gene was available (data not shown)
These results not only confirm the lack of glycan specificity in pilin glycosylation, but demonstrate the vital role that PilO plays in this process. In addition, these experiments suggest that PilO is the only requirement for pilin glycosylation that is not an integral part of another cell function.
Discussion
The structural similarity between the P. aeruginosa 1244 pilin glycan and the serotype O7 O-antigen repeating unit suggested that this saccharide was derived from the O-antigen biosynthetic pathway (Castric et al., 2001 ). This was substantiated in the present paper by two lines of evidence. In the first, defined 1244 mutants defective in specific steps of the O-antigen biosynthetic pathway were unable to glycosylate pilin, whereas complemented mutants regained that ability. In the second, the expression of cloned O-antigen biosynthesis gene clusters in strain 1244 resulted in heterologous pilin glycosylation.
An important question arising from these results concerns how pilus and O-antigen biosynthesis intersect, in terms of both metabolism and cellular location, to produce pilin glycosylation. These pathways are multistep reactions that begin in the cytoplasm and culminate at the cell exterior (Mattick et al., 1996; Darzins and Russell, 1997; Rochetta et al., 1999) . Evidence presented here indicates that a mutant (wbpL), lacking a transferase required for assembly of the O-antigen repeating unit, was unable to support pilin glycosylation. This suggests that pilin glycosylation does not occur through the sequential attachment of O-antigen sugars to pilin. This evidence, along with the relation of the glycan structure to the O-antigen (Castric et al., 2001) , also suggests that the glycosylation precursor may be the undecaprenol-bound repeating unit. If this is the case, pilin glycosylation could occur at the cell membrane in either the cytoplasm or, as a result of the Wzx-mediated transfer of the O-antigen repeating unit (Rochetta et al., 1999) , in the periplasm. In this situation, the pilin cytoplasmic membrane pool (Watts et al., 1982) would provide the protein substrate. If pilin glycosylation occurs in the periplasm, it would be topologically similar to the dolichol pathway of protein glycosylation in eukaryotes (Burda and Aebi, 1999) , with the periplasmic space functioning in a manner analogous to the lumen of the endoplasmic reticulum. This general strategy has been proposed previously for the attachment of the glycosaminoglycan and the sulphated oligosaccharides to the surface layer protein of Halobacterium halobium (Lechner and Wieland, 1989) .
Wherever these pathways converge, it is clear that PilO is the only factor required for pilin glycosylation that is not a component of either O-antigen or pilus biosynthesis. It will be necessary to determine the mechanism of action, as well as specific details of glycan and pilin substrate specificity, to clarify the role of PilO in pilin glycosylation. Although much work remains to be done in PilO characterization, patterns of glycan substrate specificity are apparent from the work presented here, where it is shown that glycosylation could use eight different O-antigens, including E. coli O157:H7, as glycosylation substrate. The fact that the O-antigens used by saccharides in this study (Fig. 7) vary so greatly in structure, size and overall charge raises the intriguing question as to how PilO would recognize these molecules. Although common sugars and linkages are seen among certain related repeating units (for example, serotypes O2, O5 and O16), no major structures are shared by all groups. The results presented suggest that P. aeruginosa does not use A-band polysaccharide or peptidoglycan biosynthesis for pilin glycosylation, as no apparent pilin glycosylation occurs in the absence of O-antigen biosynthesis. Further, a single glycan isoform is produced by pilin glycosylation (Castric et al., 2001) , indicating that polymerized O-antigen repeating units do not serve as a glycosylation substrate. These findings suggest that recognition of the glycosylation substrate may be based on a combination of molecule size and the presence of some common structural elements. For example, if the glycan is transferred to pilin via undecaprenol phosphate, PilO may recognize portions of this molecule in addition to (or instead of) the O-antigen repeating unit.
As prokaryotes produce relatively few polysaccharides, and so have limited routes for biosynthesis of these molecules, it would not be surprising to find that these organisms must use pathways dedicated to saccharide production for protein glycosylation. This appears to be the case in examples such as pilin glycosylation by N. meningitidis (Jennings et al., 1998; Powers et al., 2000; Kahler et al., 2001 ) and flagellin glycosylation by P. aeruginosa (Arora et al., 2001) . In H. halobium, a common pathway produces sulphated oligosaccharides used for glycosylation of the S-layer flagellin of this organism (Wieland et al., 1985; Lechner and Wieland, 1989 ). An analogous situation may occur in the multiple glycosylation of Campylobacter proteins (Logan et al., 1989; Guerry et al., 1996) . It is therefore unusual to find that pilin glycosylation in P. aeruginosa 1244 uses a major pathway (O-antigen biosynthesis) that normally operates to fulfil a separate physiological function. An obvious disadvantage to this arrangement is that the pilin-bound O-antigen repeating unit presents an additional antigenic target in which at least some of the antibodies directed against the lipopolysaccharide O-antigen, a major target of the immune response, would also be expected to recognize the pilus. This would be important as a monoclonal antibody reacting with the 1244 pilin glycan has been shown to block twitching motility by this organism (Castric et al., 2001) . On the other hand, the utilization of the O-antigen pathway for pilin glycosylation would represent a saving of energy expended for biosynthesis. A further advantage could be found in the low glycan substrate specificity of PilO. This property would guarantee that a pilAO operon entering the genome of a type IV pilin-producing species by reciprocal recombination would be able to code for pilin that had immediate access to the glycosylation substrate. Horizontal transfer of the ability to form glycosylated pili could then be carried out using small segments of information without the necessity for the mobilization of an entire pathogenicity island. This low specificity would also guarantee that variations in O-antigen biosynthesis (which could also be introduced by horizontal transfer), such as the addition or removal of functional groups, would not interfere with pilin glycosylation.
Previous work (Comer et al., 2002) has shown that P. aeruginosa 1244 pili are able to stimulate glycan-specific antibodies. Further, the inhibition of twitching motility, a process important to P. aeruginosa virulence, by an antiglycan monoclonal antibody (Castric et al., 2001) indicates that this structure is a potential vaccine target. Of further significance is the finding that antibodies raised against the 1244 pilus glycan recognize LPS from this organism (Comer et al., 2002) . This suggests that pilus immunization could be used to raise a protective LPSspecific T-dependent B-cell response without the disadvantages of LPS toxicity and the requirement for LPS purification. The ability of PilO to attach E. coli O157 Oantigen to 1244 pilin suggests that repeating units from a variety of Gram-negative pathogens could be used for pilin glycosylation. This raises the possibility of a pilus/Oantigen bioconjugate vaccine produced by the expression of a pathogen O-antigen cluster in a P. aeruginosa strain capable of glycosylating pilin. Such an effort will first require the determination of the range of glycan substrate specificity for PilO and the compatibility of pathogen Oantigen cluster expression with P. aeruginosa.
Experimental procedures
Culture conditions
All strains were grown aerobically on LB plates or broth cultures at 37∞C. Broth cultures were grown on a rotatory shaker at 275 r.p.m. The following antibiotics (Sigma) were used in selective media at the indicated concentrations: ampicillin at 100 mg ml -1 for E. coli; carbenicillin at 200 mg ml -1 for P. aeruginosa 1244; gentamicin at 15 mg ml -1 for E. coli and 300 mg ml -1 for P. aeruginosa 1244; tetracycline at 15 mg ml -1 and 50 mg ml -1 for E. coli and P. aeruginosa respectively. IPTG (20 mM) and Xgal (40 mg ml -1 ) (Gibco BRL) were added to solid media to determine loss of lacZ a-complementation in cloning experiments using the appropriate vector-host combinations. Pseudomonas isolation agar (PIA; Difco) was used for selecting P. aeruginosa transconjugants after the mating experiments.
Generation of 1244 wbpM null mutant
Pseudomonas aeruginosa 1244 wbpM mutants were generated by the gene replacement strategy described by Schweizer and Hoang (1995) using a previously generated Fig. 7 . Chemical structures of the O-antigen repeating units from seven serotypes of P. aeruginosa (Knirel, 1990 ) and E. coli O157:H7 (Perry et al., 1986) .
wbpM PAO1 knock-out construct (Burrows et al., 1996) . Briefly, this construct contains wbpM from P. aeruginosa strain PAO1 interrupted at the NruI site with a gentamicin resistance (Gm R ) cassette cloned into the gene replacement vector pEX100T. Homologous recombination of the wbpM PAO1 ::Gm R allele with wbpM 1244 on the chromosome was confirmed by Southern blot analysis. Chromosomal DNA from 1244 and three wbpM mutants was isolated using DNAzol reagent (Gibco BRL) according to the manufacturer's instructions and digested with XhoI. Southern hybridizations were performed using the gentamicin resistance gene aacC1 and wbpM PAO1 as separate DNA probes with a previously described protocol (Schweizer, 1993) . These probes were labelled using a non-radioactive digoxigenin-dUTP labelling system (Boehringer Mannheim), and Southern blotting was performed under high stringency as described by the manufacturer.
Cloning of wbpL from strain 1244 and construction of wbpL 1244 knock-out mutant
In Southern hybridization experiments described above for verifying the presence of the Gm R in the 1244 wbpM knockouts, a 3 kb XhoI fragment of 1244 DNA was found to hybridize to both the wbpM PAO1 and the aaC1 probe in Southern blots. This fragment should contain wbpL, which is located 5¢ to wbpM in strain PAO1. Thus, the following strategy was developed to clone wbpL 1244 . Genomic DNA from the 1244 wbpM mutant was digested with XhoI and electrophoresed on a 0.7% agarose gel. DNA bands containing XhoI fragments between 2.5 kb and 3.5 kb were isolated from the gel using GeneClean (MO BIO Laboratories), ligated to the cloning vector pBluescript-II SK and transformed into E. coli DH5a by CaCl 2 transformation (Huff et al., 1990) . Transformants containing a plasmid with the 3 kb wbpM::Gm R insert were selected for by growth on gentamicin-Luria agar plates. The presence of wbpL was verified by performing sequence analysis of the 3 kb insert of pFVAB1-SK. To generate the wbpL knock-out construct, a 1.5 kb KpnI fragment containing wbpL 1244 was then cloned into the replacement vector pEX18Ap, and an 879 bp Gm R cassette from pUCGM was inserted into the unique NruI site within wbpL 1244 ; the new construct was designated pFVAB2-18Ap. The success of constructing 1244 wbpL::Gm R mutants were confirmed by Southern blot analysis (Fig. 1) .
DNA sequencing and analysis
The DNA sequence from the 3 kb insert of pFVAB1-SK obtained from strain 1244 wbpM::Gm R was determined by the Guelph Molecular Super Centre (University of Guelph, Guelph, Ontario, Canada) using the d-Rhodamine terminator Castric (1995) cycle sequencing ready reaction kit (Perkin-Elmer). DNA sequence analysis was performed using the computer software program GENE RUNNER for Windows (Hastings Software), and nucleotide and protein alignments were performed by CLUSTALW (European Bioinformatics Institute; http://www.ebi.ac.uk/clustalw/). Nucleotide and amino acid homology searches were determined using the GenBank DNA and protein sequence databases through the National Center for Biotechnology Information BLAST network server (Altschul et al., 1997) .
Construction of pDIG5
As pDS300, a cosmid that contains the E. coli O157:H7 Oantigen gene cluster (Maurer et al., 1999) , was unable to replicate in P. aeruginosa, it was necessary to subclone the cluster region to a broad-host-range vector. An EcoRI partial digestion of pDS300 was ligated with pLAFR1 cut with the same enzyme. This DNA was packaged as lambda particles that were used to infect E. coli. Tetracycline-resistant colonies were tested for expression of O157 antigen by colony lift using a polyclonal antiserum (Difco Laboratories). Digestion of plasmid DNA with EcoRI followed by agarose electrophoresis revealed the presence of pLAFR1 vector and pDS300 insert DNA. Western immunoblotting analysis of positive clones using this same antiserum confirmed that the functional O-antigen cluster had been transferred to pLAFR1 producing pDIG5. This cosmid was mobilized to P. aeruginosa 1244 by triparental mating (Ruvkun and Ausubel, 1981) , in which the expression of O157 antigen was confirmed by immunoblotting.
LPS and pilin preparation
LPS was prepared from whole-cell lysates of P. aeruginosa according to the method of Hitchcock and Brown (1983) . Glycosylated and non-glycosylated pilin was prepared from P. aeruginosa 1244 as described previously (Castric et al., 2001) .
SDS-PAGE and isoelectric focusing
LPS was separated on 12.5% T Tris-glycine SDS-PAGE gels, whereas pilin samples were analysed using the same buffer system and 15% T resolving gels. LPS bands were visualized by the silver-staining method described by Dubray and Bezard (1982) . Pili samples to be subject to isoelectric focusing were treated with 2% b-octylglucoside for 15 min at room temperature. This material was separated in a pH gradient from either 3.5 or 2.5 to 9.0 using a Pharmacia PhastSystem apparatus in which the gels had been equilibrated with 1.0% b-octylglucoside.
Immunoblot analysis
LPS or pilin separated by SDS-PAGE was transferred to nitrocellulose membrane by electroblotting, whereas diffusion blotting was used with pilin separated by isoelectric focusing. These blots were analysed in one of two ways. For LPS from the P. aeruginosa 1244 wbpL and wbpM mutants, the membrane was blocked with 3% skim milk and immersed in hybridoma culture supernatants containing monoclonal antibody (mAb) MF29-2 (specific for serotype O7 B-band LPS; Lam et al., 1987) or mAb N1F10 (specific for the common antigen A-band LPS; Lam et al., 1989) . Detection of antibody reaction was carried out as described previously (Lam et al., 1987) . For all other blots, blocking was carried out as described previously (Castric et al., 1989) . LPS or pilin was detected using mAb 11.14 (specific for the 1244 pilin glycan and IATS serotype O7 O-antigen; Castric et al., 2001) , mAb O11 (specific for IATS serotype O11; ERFA, Westmount, Quebec, Canada), a polyclonal serum specific for E. coli O157 O-antigen (Difco, Detroit) or mAb 6.45 (specific for 1244 pilin protein; Castric and Deal, 1994) . Detection of antibody reactions has been described previously (Castric et al., 1989) .
Pilin mass determination
Pilin mass analysis by MALDI-TOF mass spectrometry was performed by Dr M. Bier at the Mellon Institute Center for Molecular Analysis, Carnegie Mellon University, using a PerSeptive Biosystems Voyager STR with DE and a high m/z detector.
